Literature DB >> 11003611

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

A Poonawala1, S P Nair, P J Thuluvath.   

Abstract

It has recently been suggested that nonalcoholic steatohepatitis (NASH) is an under-recognized cause of cryptogenic cirrhosis (CC) on the basis of higher prevalence of obesity and type II diabetes among these patients. To test this hypothesis, we studied 65 consecutive patients with advanced cirrhosis (Child-Pugh Score >/= 7) of undetermined etiology (CC) from our active waiting list for liver transplantation in January 1993, 1996, and 1999. For each patient, we selected 2 age- and sex-matched controls from the corresponding lists. The prevalence of obesity (defined as body mass index [BMI] >/= 30) and diabetes were compared between the groups. Sixteen patients (and their 32 controls) with CC were excluded as further review of records suggested other possible etiologies. Thus, the final analysis included 49 patients and 98 controls. The etiology of cirrhosis in the control group was alcohol in 16.3%, chronic viral hepatitis in 30.6%, autoimmune hepatitis in 8.2%, and primary biliary cirrhosis (PBC) or primary sclerosing cholangitis in 35.7%. The prevalence of obesity (55% vs. 24%) and type II diabetes (47% vs. 22%) was significantly higher in patients with CC compared with controls. Twenty-three percent of patients with CC had both obesity and diabetes compared with 5% among controls (P =.002). There was no difference in the prevalence of hypercholesterolemia (serum cholesterol > 200 mg/dL) between the groups. In conclusion, patients with advanced CC are more likely to be obese and diabetic compared with age- and sex-matched patients with advanced cirrhosis. This supports the hypothesis that NASH may be an etiological factor in some of the patients with CC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003611     DOI: 10.1053/jhep.2000.17894

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  103 in total

1.  Nutrition in hepatic failure and liver transplantation.

Authors:  J Aranda-Michel
Journal:  Curr Gastroenterol Rep       Date:  2001-08

2.  Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program.

Authors:  Cary H Patt; Hwan Y Yoo; Kourosh Dibadj; John Flynn; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 3.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 4.  Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Metin Basaranoglu; Serra Kayacetin; Nevin Yilmaz; Ertugrul Kayacetin; Orhan Tarcin; Abdullah Sonsuz
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

5.  Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.

Authors:  Jasbir Makker; Hassan Tariq; Jonathan N Bella; Kishore Kumar; Chukwunonso Chime; Harish Patel; Muhammad Umar Kamal; Danial Shaikh; Vamshidhar Vootla; Bharat Bajantri; Umut Gomceli; Mohammad Alshelleh; Richard Peralta; Aiyi Zhang; Sridhar Chilimuri
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

6.  Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation.

Authors:  Karim Samara; Chen Liu; Consuelo Soldevila-Pico; David R Nelson; Manal F Abdelmalek
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 7.  NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Authors:  Elisabetta Bugianesi; Ester Vanni; Giulio Marchesini
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

8.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 9.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

10.  Dietary composition and nonalcoholic fatty liver disease.

Authors:  Steven Solga; Amir R Alkhuraishe; Jeanne M Clark; Mike Torbenson; Ashli Greenwald; Anna Mae Diehl; Thomas Magnuson
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.